Company Summary

RMCM identifies and marries Chinese drug requirements with prospective US generic pharmaceutical (FDA Approved) Manufacturers. RMCM manages the Chinese CFDA drug registration. Upon CFDA registration, RMCM will then purchase the generic drugs and resell to Chinese distributors. The drugs are shipped directly from US manufacturer to China. The distributors have pre-qualified the drug and agreed to purchasing quantities before registration.

Team

Mark Fitzgerald

CEO - Co Founder

As managing member of RMC Energy (Sister Company), Mark has acquired exclusive marketing rights for multiple US innovative fuel additives exporting the additives to China refineries. Mark has been key in partnering with US generic drug manufacturers and responsible for sales, strategic planning, and registration with the Chinese government. winner of the Missouri SBA 2008 Exporter of the Year award for sales of over $39 M in six years.

Charlie Chen

VP of China Operations - Co Founder

Mr. Chen was one of the first to earn an MBA in China and co founder of RMC Energy. He has 30 years experience in China exporting and importing. With his military background, Mr. Chen has developed high level relationships with the local and central government. He thoroughly understands the nuances of doing business in china and gives RMC Medical the advantage in coordinating drug registrations and negotiating buyer contracts.

Robert Chan

VP of Asian Markets - Co Founder

Mr. Chan was born and raised in Hong Kong and is fluent in Chinese and English. He has over 20 years of experience in importing/exporting with China. Mr. Chan has been key in achieving governmental approvals for products in China. He is responsible for bridging the cultures and business differences between US and China, providing solutions to problems between distributors and manufacturers.

Eric McCabe

VP of US Operations

20 years of industry experience and six years of “Big 5 Consulting” project management and enterprise resource planning (ERP) implementation experience with an emphasis in generic pharmaceutical companies. In addition, five year’s experience in co-founding, developing and selling a national franchise within five years. Responsible for presenting company value proposition and leading and managing target pharmaceutical companies.